Aurora Investment Managers’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$245K Buy
+2,707
New +$227K 0.15% 51
2026
Q1
Sell
-2,707
Closed -$231K 33
2025
Q4
$231K Hold
2,707
0.13% 45
2025
Q3
$211K Hold
2,707
0.11% 47
2025
Q2
$212K Buy
+2,707
New +$202K 0.13% 46
2025
Q1
Sell
-2,707
Closed -$200K 45
2024
Q4
$200K Buy
+2,707
New +$189K 0.13% 46
2024
Q3
Sell
-2,707
Closed -$250K 46
2024
Q2
$250K Hold
2,707
0.18% 48
2024
Q1
$259K Hold
2,707
0.19% 50
2023
Q4
$206K Buy
+2,707
New +$188K 0.16% 48
2023
Q3
Sell
-3,382
Closed -$319K 46
2023
Q2
$319K Buy
3,382
+675
+25% +$58.7K 0.24% 42
2023
Q1
$224K Hold
2,707
0.19% 45
2022
Q4
$202K Hold
2,707
0.2% 48
2022
Q3
$224K Hold
2,707
0.22% 47
2022
Q2
$257K Hold
2,707
0.25% 48
2022
Q1
$319K Buy
+2,707
New +$304K 0.24% 43
2020
Q1
Sell
-5,112
Closed -$398K 45
2019
Q4
$398K Buy
+5,112
New +$399K 0.39% 42

Other funds holding EW

Aurora Investment Managers's EW Position: Q2 2026 in Review

Aurora Investment Managers opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,707 shares worth $245K. The stake represents 0.15% of the portfolio and ranks #51 among its holdings. This is a return to the name: Aurora Investment Managers previously reported a position in EW as recently as Q4 2025.

Aurora Investment Managers first reported a position in EW in Q4 2019 and has held it in 15 quarters since. The position peaked at $398K in Q4 2019. 500 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Aurora Investment Managers held 2,707 shares of Edwards Lifesciences worth $245K as of Q2 2026.
  • Edwards Lifesciences was a new Aurora Investment Managers position in Q2 2026.
  • Edwards Lifesciences made up 0.15% of Aurora Investment Managers's portfolio in Q2 2026, its #51 holding.
  • Aurora Investment Managers first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 15 quarters since.
  • Aurora Investment Managers's Edwards Lifesciences position peaked at $398K in Q4 2019.
  • 500 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Aurora Investment Managers's 13F filing for Q2 2026, filed 8 Jul 2026.